Inventor · disambiguated record
Hans-Michael Eggenweiler
Also filed as: EGGENWEILER HANS-MICHAEL
37 granted patents·15 pending applications·238 citations·filing 2000–2013
97Inventor score
Files withMERCK PATENT GMBH28EGGENWEILER HANS-MICHAEL10HOELZEMANN GUENTER2BUCHSTALLER HANS-PETER1MERK PANTENT GMBH1
Top patents by PatentIndex Score
52 records- 0189US6737436B1Pyrrole derivatives as phosphodiesterase VII inhibitorsMERCK PATENT GMBH·Filed 2000·Granted May 18, 2004·39 cites·13 claims
- 0287US6884800B1Imidazole compounds used as phosphodiesterase VII inhibitorsMERCK PATENT GMBH·Filed 2000·Granted Apr 26, 2005·31 cites·16 claims
- 0385US7544684B2Hydrazono-malonitrilesMERCK PATENT GMBH·Filed 2006·Granted Jun 9, 2009·9 cites·10 claims
- 0484US6531498B1Isoxazole derivatives to be used as phosphodiesterase VII inhibitorsMERCK PATENT GMBH·Filed 2000·Granted Mar 11, 2003·22 cites·20 claims
- 0582US8969335B2Benzonitrile derivatives as kinase inhibitorsHOELZEMANN GUENTER·Filed 2012·Granted Mar 3, 2015·7 cites·1 claims
- 0682US7906657B21,5-diphenylpyrazoles II as HSP90 inhibitorsMERCK PATENT GMBH·Filed 2007·Granted Mar 15, 2011·5 cites·30 claims
- 0782US7491742B2Imidazole derivatives as phosphodiesterase VII inhibitorsMERCK PATENT GMBH·Filed 2004·Granted Feb 17, 2009·13 cites·4 claims
- 0881US8546565B2Quinazolinamide derivativesEGGENWEILER HANS-MICHAEL·Filed 2009·Granted Oct 1, 2013·5 cites·23 claims
- 0981US8183279B21,3-dihydroisoindole derivativesEGGENWEILER HANS MICHAEL·Filed 2008·Granted May 22, 2012·5 cites·21 claims
- 1081US7947696B22-amino-4-phenylquinazoline derivatives and the use thereof as HSP90 modulatorsMERCK PATENT GMBH·Filed 2006·Granted May 24, 2011·5 cites·19 claims
- 1180US7019013B2SulfamidothienopyrimidinesMERCK PATENT GMBH·Filed 2001·Granted Mar 28, 2006·15 cites·16 claims
- 1279US7989625B2ThienopyridinesMERCK PATENT GMBH·Filed 2006·Granted Aug 2, 2011·4 cites·1 claims
- 1379US7563790B2Pyridazine derivativesMERCK PATENT GMBH·Filed 2006·Granted Jul 21, 2009·3 cites·18 claims
- 1479US7498334B2Pyrrolopyrimidines as phosphodiesterase VII inhibitorsMERCK PATENT GMBH·Filed 2002·Granted Mar 3, 2009·12 cites·4 claims
- 1579US7470687B2Aryl oximesMERCK PATENT GMBH·Filed 2006·Granted Dec 30, 2008·3 cites·22 claims
- 1679US7135471B2Aryl oximesMERCK PATENT GMBH·Filed 2003·Granted Nov 14, 2006·11 cites·15 claims
- 1779US6777419B1Pyrazolo [4,3-d]pyrimidinesMERCK PATENT GMBH·Filed 2000·Granted Aug 17, 2004·12 cites·16 claims
- 1877US7977343B2Adenine derivativesMERCK PATENT GMBH·Filed 2006·Granted Jul 12, 2011·3 cites·14 claims
- 1977US7790723B2Thiazole derivatives as phosphodiesterase IV inhibitorsMERCK PATENT GMBH·Filed 2003·Granted Sep 7, 2010·11 cites·3 claims
- 2075US7129241B2Pyridazine derivativesMERCK PATENT GMBH·Filed 2003·Granted Oct 31, 2006·8 cites·17 claims
- 2173US9045493B2Furo[3,2-b]- and thieno[3,2-b]pyridin derivativesMERCK PATENT GMBH·Filed 2013·Granted Jun 2, 2015·2 cites·7 claims
- 2271US7943637B2Thienopyridine derivatives and the use thereof as HSP90 modulatorsMERCK PATENT GMBH·Filed 2006·Granted May 17, 2011·1 cites·16 claims
- 2371US6780867B2ThienopyrimidinesMERCK PATENT GMBH·Filed 2001·Granted Aug 24, 2004·5 cites·20 claims
- 2470US8119795B2Triazole derivatives IIEGGENWEILER HANS-MICHAEL·Filed 2007·Granted Feb 21, 2012·1 cites·24 claims
- 2569US8722903B2Indazole derivatives for the treatment of HSP9O-induced diseasesBUCHSTALLER HANS-PETER·Filed 2007·Granted May 13, 2014·1 cites·4 claims
- 2667US9102675B23-Cyanoaryl-1H-pyrrolo[2,3-B] pyridine derivativesMERCK PATENT GMBH·Filed 2012·Granted Aug 11, 2015·1 cites·14 claims
- 2766US7312328B2BenzoylpyridazinesMERCK PATENT GMBH·Filed 2001·Granted Dec 25, 2007·3 cites·11 claims
- 2862US7141572B2Hydrazono-malonitrilesMERCK PATENT GMBH·Filed 2002·Granted Nov 28, 2006·1 cites·12 claims
- 2956US8816070B2Triazole derivative as an HSP 90 inhibitorEGGENWEILER HANS MICHAEL·Filed 2007·Granted Aug 26, 2014·0 cites·7 claims
- 3049US8501754B2Quinazolinamide derivativesEGGENWEILER HANS-MICHAEL·Filed 2008·Granted Aug 6, 2013·0 cites·19 claims
- 3149US2010256137A1Indazolamide derivativesMERCK PATENT GMBH·Filed 2008·Application pending·0 cites
- 3244US2011028485A11,5-diphenylpyrazoles ii as hsp90 inhibitorsEGGENWEILER HANS-MICHAEL·Filed 2010·Application pending·0 cites
- 3343US8618285B2Triazole derivativesEGGENWEILER HANS-MICHAEL·Filed 2006·Granted Dec 31, 2013·0 cites·14 claims
- 3443US7932401B21,5-diphenylpyrazolesMERCK PATENT GMBH·Filed 2005·Granted Apr 26, 2011·0 cites·3 claims
- 3543US2008045529A1Use Of ThienopyrimidinesMERCK PATENT GMBH·Filed 2004·Application pending·0 cites
- 3642US7485639B24-(benzylidene-amino)-3-(methylsulfanyl)-4h-(1,2,4)triazin-5-one derivatives having a PDE-IV inhibiting and TNF-antagonistic effect for the treatment of cardiac diseases and allergiesMERCK PATENT GMBH·Filed 2002·Granted Feb 3, 2009·0 cites·10 claims
- 3742US6960661B2[7-(3-chloro-4-methoxybenzlamino)-1-methyl-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-ylmethoxy]acetic acid, synthesis thereof and intermediates used thereinMERCK PATENT GMBH·Filed 2001·Granted Nov 1, 2005·0 cites·4 claims
- 3842US2008090880A13-(2-Hydroxyphenyl) Pyrazoles and Thier Use as Hsp90 ModulatorsEGGENWEILER HANS-MICHAEL·Filed 2005·Application pending·0 cites
- 3942US2004235845A1Use of phosphodiesterase iv inhibitorsFiled 2002·Application pending·0 cites
- 4042US2004259863A1Type 4 phosphodiesterase inhibitors and uses thereofFiled 2002·Application pending·0 cites
- 4141US9273029B2Pyridine-and pyrazine derivativesHOELZEMANN GUENTER·Filed 2012·Granted Mar 1, 2016·0 cites·36 claims
- 4241US2004063730A1Pharmacuetical formulation comprising puyrazolo[4,-3-d]pyrimidines and antithrombotics, calcium antagonists, or prostaglandins or prostaglandin derivativesFiled 2001·Application pending·0 cites
- 4341US2004072846A1Pharmaceutical formulation containing thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivativesFiled 2001·Application pending·0 cites
- 4441US2004077664A1Pharmaceutical formulation comprising pyrazolo[4,3-d]pyrimidine and nitrates or thienopyrimidines and nitratesFiled 2001·Application pending·0 cites
- 4541US2004063731A1Pharmaceutical formulation comprising pyrazolo[4,3-d]pyrimidines and endothelin receptor antagonists or thienopyrimidines and endothelin receptor antagonistsFiled 2002·Application pending·0 cites
- 4641US2004058940A1Pharmaceutical formulation comprising thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives (2)Filed 2001·Application pending·0 cites
- 4740US2004023990A1Use of pyrazolo[4,3-d]pyrimidinesFiled 2001·Application pending·0 cites
- 4840US2004034040A1Use of thienopyrimidinesFiled 2001·Application pending·0 cites
- 4940US2004023991A1Use of pyrazolo[4,3-d]pyrimidinesFiled 2001·Application pending·0 cites
- 5038US8791129B2Phenylquinazoline derivativesEGGENWEILER HANS-MICHAEL·Filed 2011·Granted Jul 29, 2014·0 cites·2 claims
Showing the top 50 of 52 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Hans-Michael Eggenweiler files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →